|
基于数据挖掘探讨中药复方治疗糖尿病肾脏病气阴两虚兼血瘀证用药规律
|
Abstract:
目的:运用数据挖掘方法,研究中药复方治疗糖尿病肾脏病(DKD)气阴两虚兼血瘀证的用药规律,为临床遣方用药提供依据。方法:检索中国知网、维普、万方、中国生物医学文献数据库近10年收录的中药复方治疗DKD气阴两虚兼血瘀证的临床研究文献,对检索文献进行筛选,提取合格文献中方药信息构建数据库,进行频次分析、关联规则分析和系统聚类分析。结果:共纳入163篇合格文献,包含163首有效处方,涉及170味中药,中药总频次为1874次。其中,使用频次 > 20次的高频中药有26味,排名前5位的中药分别是黄芪、丹参、山茱萸、山药和生地黄。高频中药共涉及8种功效类别,使用频率靠前的为补虚药、活血化瘀药、收涩药、清热药、利水渗湿药。高频中药性味归经分析表明,药性以平、温、寒为主;药味以甘、苦、辛为主;归经以肝、脾、肾、肺为主。关联规则分析表明,“山茱萸→黄芪”、“黄芪、山药→山茱萸”和“茯苓、山药、山茱萸→黄芪”分别为2种、3种和4种药物关联规则中支持度最高的组合。系统聚类分析显示,聚为4类时最佳。结论:中药复方治疗DKD气阴两虚兼血瘀证以益气养阴、活血通络为基本大法,重在健脾益肺、补益肝肾;用药以甘补、苦坚、辛行,寒温平调;提炼出“黄芪、山茱萸、山药”为核心药物组合,黄芪葛根汤、补阳还五汤、参芪地黄汤、水陆二仙丹为常用处方。
Objective: Using the method of data mining, this paper studies the medication rule of traditional Chinese medicine compound in the treatment of diabetic kidney disease (DKD) with Qi-Yin deficiency and blood stasis syndrome, and provides the basis for clinical prescription. Methods: The clinical research literatures of traditional Chinese medicine compound for the treatment of DKD with qi-yin deficiency and blood stasis syndrome collected by CNKI, VIP, Wanfang Data and CBM database in recent 10 years were retrieved. The retrieved literatures were screened, and the prescription information in the qualified literature was extracted to construct the database for frequency analysis, association rule analysis and systematic clustering analysis. Results: A total of 163 eligible literatures were included, including 163 effective prescriptions, involving 170 traditional Chinese medicines. The total frequency of traditional Chinese medicines was 1874 times, and 26 high-frequency traditional Chinese medicines with a frequency > 20 times were obtained. Among them, the top 5 traditional Chinese medicines with the highest frequency were Astragalus membranaceus, Salvia miltiorrhiza, Cornus officinalis, Chinese yam and Rehmannia glutinosa. The high-frequency traditional Chinese medicine involves a total of 8 efficacy categories, and the most frequently used are tonic drugs, blood-activating and stasis-resolving drugs, astringent drugs, heat-clearing drugs, and damp-draining diuretics. According to the analysis of the property, taste and meridian tropism of high-frequency traditional Chinese medicine, the medicinal properties are mainly flat, warm and cold; the medicinal tastes are mainly sweet, bitter and spicy; the
[1] | Zhang, X., Kong, J. and Yun, K. (2020) Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies. Journal of Diabetes Research, 2020, Article ID: 2315607. https://doi.org/10.1155/2020/2315607 |
[2] | Yang, C., Wang, H., Zhao, X., Matsushita, K., Coresh, J., Zhang, L., et al. (2020) CKD in China: Evolving Spectrum and Public Health Implications. American Journal of Kidney Diseases, 76, 258-264. https://doi.org/10.1053/j.ajkd.2019.05.032 |
[3] | Tuttle, K.R., Agarwal, R., Alpers, C.E., Bakris, G.L., Brosius, F.C., Kolkhof, P., et al. (2022) Molecular Mechanisms and Therapeutic Targets for Diabetic Kidney Disease. Kidney International, 102, 248-260. https://doi.org/10.1016/j.kint.2022.05.012 |
[4] | 中国中西医结合学会内分泌专业委员会糖尿病肾脏病专家委员会, 中国微循环学会中医与微循环专业委员会. 糖尿病肾脏病中西医结合防治专家共识(2023版) [J]. 中华糖尿病杂志, 2023, 15(8): 690-702. |
[5] | 柳晶, 王金泉. 糖尿病肾病药物治疗的现状和进展[J]. 肾脏病与透析肾移植杂志, 2022, 31(5): 470-474. |
[6] | 程培国. 黄芪葛根汤治疗糖尿病肾病气阴两虚兼瘀阻肾络证的效果分析[J]. 智慧健康, 2018, 4(12): 22-23. |
[7] | 吴雪. 研究分析黄芪葛根汤治疗糖尿病肾病气阴两虚兼瘀阻肾络证的效果评价[J]. 糖尿病新世界, 2020, 23(5): 83-84. |
[8] | 杨帆, 马赟, 刘利飞, 等. 加减补阳还五汤对早期糖尿病肾病临床疗效及足细胞损伤的保护作用[J]. 中药药理与临床, 2023: 1-9. |
[9] | 杜小梅, 潘薇, 梁颖兰, 等. 参芪地黄汤加减治疗气阴两虚型糖尿病肾病疗效观察及对肠道菌群和炎症因子的影响[J]. 中药新药与临床药理, 2021, 32(4): 566-572. |
[10] | 陈龙. 水陆二仙丹加减方治疗早期糖尿病肾病临床观察[J]. 中国医学创新, 2017, 14(34): 111-114. |
[11] | 郑启艳, 孙鲁英, 姚志, 等. 糖尿病肾脏病III~IV期患者人体成分变化及与中医证型的相关性[J]. 中华中医药杂志, 2021, 36(5): 2978-2982. |
[12] | 莫超, 赵洁, 黄国东. 基于文献的糖尿病肾脏病患者中医证候及证素分布规律研究[J]. 中医杂志, 2023, 64(8): 848-852. |
[13] | 赵玲, 曾慧妍, 张锦明, 等. 基于中医传承辅助系统的早中期糖尿病肾病气阴两虚血瘀证治疗方剂组方分析及新方发现[J]. 世界中西医结合杂志, 2018, 13(5): 613-617. |
[14] | 潘晓, 赵玉, 杨银, 等. 糖尿病肾病气阴两虚夹瘀型用药规律研究[J]. 中国中西医结合肾病杂志, 2023, 24(10): 901-904. |
[15] | 国家药典委员会. 中华人民共和国药典: 一部[M]. 北京: 中国医药科技出版社, 2020. |
[16] | 国家中医药管理局《中华本草》编委会. 中华本草: 精选本[M]. 上海: 上海科学技术出版社, 1998. |
[17] | 周祯祥, 唐德才. 中药学[M]. 北京: 中国中医药出版社, 2016. |
[18] | 但文超, 赵国桢, 何庆勇, 等. 中医药处方数据挖掘的常见问题辨析与展望[J]. 中国中药杂志, 2023, 48(17): 4812-4818. |
[19] | 穆兰澄, 顾成娟, 徐立鹏, 等. 平性药药性及应用特点[J]. 中医杂志, 2017, 58(1): 23-26+45. |
[20] | Guo, M., Gao, J., Jiang, L. and Dai, Y. (2023) Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway. Drug Design, Development and Therapy, 17, 2107-2118. https://doi.org/10.2147/dddt.s411211 |
[21] | Chen, Z., Liang, H., Yan, X., Liang, Q., Bai, Z., Xie, T., et al. (2023) Astragalus Polysaccharide Promotes Autophagy and Alleviates Diabetic Nephropathy by Targeting the lncRNA Gm41268/PRLR Pathway. Renal Failure, 45, Article ID: 2284211. https://doi.org/10.1080/0886022x.2023.2284211 |
[22] | Xing, L., Fang, J., Zhu, B., Wang, L., Chen, J., Wang, Y., et al. (2021) Astragaloside IV Protects against Podocyte Apoptosis by Inhibiting Oxidative Stress via Activating PPARγ-Klotho-FoxO1 Axis in Diabetic Nephropathy. Life Sciences, 269, Article ID: 119068. https://doi.org/10.1016/j.lfs.2021.119068 |
[23] | He, J., Cui, J., Shi, Y., Wang, T., Xin, J., Li, Y., et al. (2023) Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis. Journal of Diabetes Research, 2023, Article ID: 7423661. https://doi.org/10.1155/2023/7423661 |
[24] | Du, Q., Fu, Y., Shu, A., Lv, X., Chen, Y., Gao, Y., et al. (2021) Loganin Alleviates Macrophage Infiltration and Activation by Inhibiting the MCP-1/CCR2 Axis in Diabetic Nephropathy. Life Sciences, 272, Article ID: 118808. https://doi.org/10.1016/j.lfs.2020.118808 |
[25] | Gao, X., Liu, Y., Wang, L., Sai, N., Liu, Y. and Ni, J. (2020) Morroniside Inhibits H2O2-Induced Podocyte Apoptosis by Down-Regulating NOX4 Expression Controlled by Autophagy in Vitro. Frontiers in Pharmacology, 11, Article ID: 533809. https://doi.org/10.3389/fphar.2020.533809 |
[26] | 高子涵, 李瑞芳, 吕行直, 等. 山药多糖对糖尿病肾病小鼠肾功能和醛糖还原酶通路的影响[J]. 中药材, 2019, 42(3): 643-646. |
[27] | 于官正, 李鸿, 涂星, 等. 基于网络药理学和动物实验探讨黄芪葛根汤治疗糖尿病肾病的作用[J]. 中成药, 2023, 45(9): 3097-3103. |
[28] | 郑琳琳, 边东, 郭登洲. 补阳还五汤对糖尿病肾病小鼠Nrf2/HO-1通路的作用及机制研究[J]. 中药药理与临床, 2024, 40(4): 42-47. |
[29] | 崔家霖, 高彦彬. 水陆二仙丹治疗糖尿病肾病机制的网络药理学研究[J]. 中药新药与临床药理, 2021, 32(7): 979-987. |